Infant Formula and Dietary Supplement Use Among Infants and Toddlers, Aged 0 to 23 Months, NHANES, 2019 to March 2020

Edwina A Wambogo1, Suruchi Mishra, Nicholas Ansai2

  • 1Office of Dietary Supplements (ODS), at the NIH.

Nutrition Today
|September 17, 2025
PubMed

Insights

Nearly half of infants and toddlers used infant formula (IF) in 2019-2020, with most users being younger infants. Many IF products contained key nutrients and bioactives like docosahexaenoic acid, but concurrent use of dietary supplements was also noted.

Area of Science:

  • Nutrition Science
  • Pediatric Nutrition
  • Public Health

Background:

  • Infant formula (IF) is a critical nutrient source for infants and toddlers lacking adequate maternal nutrition.
  • Monitoring IF use, composition, and nutrient contribution is essential for this vulnerable population.
  • Understanding IF consumption patterns informs public health strategies and nutritional guidance.

Purpose of the Study:

  • To assess the prevalence of IF use among US infants and toddlers (0-23 months).
  • To analyze the nutrient content and presence of bioactives in commonly used IF products.
  • To determine the co-consumption of IF with dietary supplements (DSs) in this age group.

Main Methods:

  • Analysis of data from 389 infants and toddlers from the 2019-2020 National Health and Nutrition Examination Survey (NHANES).
  • Estimation of IF usage rates, nutrient content per 100 kcal, and prevalence of specific bioactives (DHA, probiotics, prebiotics).
  • Assessment of frequently used IF brands and the concurrent use of IF with DSs.

Main Results:

  • 45.7% of infants and toddlers consumed IF in the past 14 days, primarily those aged 0-11 months.
  • Most IFs met US Food and Drug Administration (FDA) nutrient standards; 68% of infant IF users consumed products with docosahexaenoic acid (DHA).
  • 13.1% of IF users also consumed DSs, with higher rates in younger infants (0-5 months).

Conclusions:

  • Infant formula is widely used by young children, with significant consumption of products containing DHA and other bioactives.
  • Concurrent use of IF and DSs highlights the need for comprehensive dietary assessments.
  • Further research is needed to fully understand nutrient and bioactive intakes from IF and DSs in infants and toddlers.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
256
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
246
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
853
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
773
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
1.3K